Strides Arcolab updates on its acquisition of Aspen's generic pharmaceutical business in Australia

Image
Capital Market
Last Updated : Aug 31 2015 | 4:29 PM IST

Acquired business to be consolidated with Strides effective 01 September 2015

Strides Arcolab announced that the Company has achieved closure on completion of closing conditions and statutory / regulatory approvals for acquiring generic pharmaceutical business in Australia and related assets from Aspen. The acquired business will be integrated and consolidated with Strides effective 01 September 2015.

Powered by Capital Market - Live News

More From This Section

First Published: Aug 31 2015 | 3:04 PM IST

Next Story